Soleus Capital Management, L.P. Portfolio Holdings

Soleus Capital Management, L.P.

$1.44 Billion
Q4 2024

Soleus Capital Management, L.P. has filed its 13F form on February 14, 2025 for Q4 2024 where it was disclosed a total value porftolio of $1.44 Billion distributed in 81 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Novo Cure LTD with a value of $81.6M, Tg Therapeutics, Inc. with a value of $80.7M, Biomarin Pharmaceutical Inc with a value of $65.8M, Krystal Biotech, Inc. with a value of $56.1M, and Grifols Sa with a value of $49.1M.

Examining the 13F form we can see an increase of $259M in the current position value, from $1.18B to 1.44B.

Soleus Capital Management, L.P. is based out at Greenwich, CT

Below you can find more details about Soleus Capital Management, L.P. portfolio as well as his latest detailed transactions.

Portfolio value $1.44 Billion

Healthcare: $1.17 Billion

ETFs: $270 Million

Stock Holdings Table Market Cap. of $200 Billions or more

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
AZN Astrazeneca PLC Healthcare	$235B	$26.8 Million 1.87% of portfolio	409,000	Q4 2024 New
LLY Eli Lilly & CO Healthcare	$788B	$9 Million 0.63% of portfolio	11,658	Q4 2024 Reduced 39.6%

Summary

Portfolio
No. of Stocks 81
Current Value $1.44 Billion
Prior Value $1.18 Billion
Filing
Period Q4 2024
Filing Date February 14, 2025
Form Type 13F-HR
Activity in Q4 2024
New Purchases 24 stocks
Additional Purchases 21 stocks
Sold out of 0 stocks
Reduced holdings in 23 stocks

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Soleus Capital Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Soleus Capital Management, L.P. with notifications on news.

Account

Soleus Capital Management, L.P. Portfolio Holdings